Katayama, D., Yanagawa, M., Matsunaga, K., Watabe, H., Watabe, T., Kato, H., . . . Tomiyama, N. (2021). Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival. Nature Portfolio.
Chicago Style (17th ed.) CitationKatayama, Daisuke, et al. Greater Reductions in Blood Flow After Anti-angiogenic Treatment in Non-small Cell Lung Cancer Patients Are Associated with Shorter Progression-free Survival. Nature Portfolio, 2021.
MLA (8th ed.) CitationKatayama, Daisuke, et al. Greater Reductions in Blood Flow After Anti-angiogenic Treatment in Non-small Cell Lung Cancer Patients Are Associated with Shorter Progression-free Survival. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.